And the most recent article came out of JAMA in 2024, and they found that for every 1 g increase in urinary sodium, you ...

Johnson & Johnson (NYSE:JNJ) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 26, Johnson & ...

Children conceived through assisted reproductive technology (ART) were modestly more likely to develop asthma, allergic ...

HealthDay News — Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study published in Nutrients.

The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...

Nemolizumab, which targets the interleukin-31 pathway, rapidly improves itch and sleep in people with atopic dermatitis and ...

Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...

Adults with atopic eczema are significantly more likely to experience suicidal thoughts than those without the skin condition ...

Due to eczema, asthma and allergies being so closely connected, coordinated care plays a critical role in long-term outcomes. Allergists are uniquely trained to manage these conditions together rather ...

A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new ...

A rash that doesn't heal may be a sign of cancer. Basal cell carcinoma is the most common type of skin cancer. Petechiae can resemble rashes but don't typically itch. A rash that doesn’t heal or go ...